114 related articles for article (PubMed ID: 8996651)
1. Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane.
Uchiyama T; Yamamoto A; Hatano H; Fujita T; Muranishi S
Biol Pharm Bull; 1996 Dec; 19(12):1618-21. PubMed ID: 8996651
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
[TBL] [Abstract][Full Text] [Related]
3. Effects of various absorption enhancers on the intestinal absorption of water soluble drugs by in vitro Ussing chamber method: correlation with an in situ absorption experiment.
Sugiyama T; Yamamoto A; Kawabe Y; Uchiyama T; Quan YS; Muranishi S
Biol Pharm Bull; 1997 Jul; 20(7):812-4. PubMed ID: 9255426
[TBL] [Abstract][Full Text] [Related]
4. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
5. Transport of drugs across the Xenopus pulmonary membrane and their absorption enhancement by various absorption enhancers.
Okumura S; Fukuda Y; Takahashi K; Fujita T; Yamamoto A; Muranishi S
Pharm Res; 1996 Aug; 13(8):1247-51. PubMed ID: 8865321
[TBL] [Abstract][Full Text] [Related]
6. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
8. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
9. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
10. Differences in the promotion mechanism of the colonic absorption of antipyrine, phenol red and cefmetazole.
Shiga M; Hayashi M; Horie T; Awazu S
J Pharm Pharmacol; 1987 Feb; 39(2):118-23. PubMed ID: 2881996
[TBL] [Abstract][Full Text] [Related]
11. Molecular weight-dependent lymphatic transfer of fluorescein isothiocyanate-labeled dextrans after intrapulmonary administration and effects of various absorption enhancers on the lymphatic transfer of drugs in rats.
Hanatani K; Takada K; Yoshida N; Nakasuji M; Morishita Y; Yasako K; Fujita T; Yamamoto A; Muranishi S
J Drug Target; 1995; 3(4):263-71. PubMed ID: 8821000
[TBL] [Abstract][Full Text] [Related]
12. Does bacitracin have an absorption-enhancing effect in the intestine?
Gotoh S; Nakamura R; Nishiyama M; Fujita T; Yamamoto A; Muranishi S
Biol Pharm Bull; 1995 May; 18(5):794-6. PubMed ID: 7493005
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic transfer of macromolecules after intrapulmonary administration in the presence or absence of various absorption enhancers in rats.
Muranishi S; Fujita T; Murakami M; Yamamoto A
Pharmazie; 1996 May; 51(5):331-6. PubMed ID: 8710955
[TBL] [Abstract][Full Text] [Related]
14. Effects of various absorption promoters on pulmonary absorption of drugs with different molecular weights.
Morita T; Yamamoto A; Hashida M; Sezaki H
Biol Pharm Bull; 1993 Mar; 16(3):259-62. PubMed ID: 7689890
[TBL] [Abstract][Full Text] [Related]
15. Intestinal absorption of raltitrexed and evaluation of the effects of absorption enhancers.
Yu Y; Lu Y; Zhao X; Li X; Yin Z
Pharmazie; 2013 Sep; 68(9):732-43. PubMed ID: 24147341
[TBL] [Abstract][Full Text] [Related]
16. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility.
Swenson ES; Milisen WB; Curatolo W
Pharm Res; 1994 Aug; 11(8):1132-42. PubMed ID: 7971714
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.
Narkar Y; Burnette R; Bleher R; Albrecht R; Kandela A; Robinson JR
Pharm Res; 2008 Jan; 25(1):25-38. PubMed ID: 18161013
[TBL] [Abstract][Full Text] [Related]
18. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
[TBL] [Abstract][Full Text] [Related]
19. Effects of protease inhibitors on the absorption of phenol red and fluorescein isothiocyanate dextrans from the rat intestine.
Gotoh S; Nakamura R; Nishiyama M; Quan YS; Fujita T; Yamamoto A; Muranishi S
J Pharm Sci; 1996 Aug; 85(8):858-62. PubMed ID: 8863277
[TBL] [Abstract][Full Text] [Related]
20. Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats.
Fan D; Wu X; Dong W; Sun W; Li J; Tang X
Drug Dev Ind Pharm; 2013 Sep; 39(9):1447-56. PubMed ID: 23020091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
